W. Keith Henry

3.1k total citations · 1 hit paper
16 papers, 2.3k citations indexed

About

W. Keith Henry is a scholar working on Infectious Diseases, Emergency Medicine and Virology. According to data from OpenAlex, W. Keith Henry has authored 16 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 11 papers in Emergency Medicine and 9 papers in Virology. Recurrent topics in W. Keith Henry's work include HIV-related health complications and treatments (11 papers), HIV/AIDS drug development and treatment (10 papers) and HIV Research and Treatment (9 papers). W. Keith Henry is often cited by papers focused on HIV-related health complications and treatments (11 papers), HIV/AIDS drug development and treatment (10 papers) and HIV Research and Treatment (9 papers). W. Keith Henry collaborates with scholars based in United States, Vietnam and Philippines. W. Keith Henry's co-authors include Judith S. Currier, Judith A. Aberg, Richard Haubrich, Manette T. Niu, Holly Gundacker, David Katzenstein, Martin Hirsch, Scott M. Hammer, Robert T. Schooley and Michael M. Lederman and has published in prestigious journals such as New England Journal of Medicine, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

W. Keith Henry

16 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

1996 768 citations Scott M. Hammer, David Katzenstein et al. New England Journal of Medicine profile →

Peers

W. Keith Henry

VIROL

EPIDE

Philippe Flandre France

Cassy Workman Australia

Camlin Tierney United States

Natasa Rajicic United States

Sara Hughes United Kingdom

Beverly Alston United States

Linda Morfeldt Sweden

Gilbert R. Kaufmann Australia

Daniel Podzamczer Spain

Bach‐Yen Nguyen United States

Philippe Flandre France

W. Keith Henry

1.9k ×1.4

498 ×0.4

1.6k ×1.4

VIROL

460 ×1.3

EPIDE

72 ×0.3

Citations per year, relative to W. Keith Henry W. Keith Henry (= 1×) peers Philippe Flandre

Countries citing papers authored by W. Keith Henry

Since Specialization

Citations

This map shows the geographic impact of W. Keith Henry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Keith Henry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Keith Henry more than expected).

Fields of papers citing papers by W. Keith Henry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Keith Henry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Keith Henry. The network helps show where W. Keith Henry may publish in the future.

Co-authorship network of co-authors of W. Keith Henry

This figure shows the co-authorship network connecting the top 25 collaborators of W. Keith Henry. A scholar is included among the top collaborators of W. Keith Henry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Keith Henry. W. Keith Henry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Wilson, Eleanor, Amrit Singh, Katherine Huppler Hullsiek, et al.. (2014). Monocyte-Activation Phenotypes Are Associated With Biomarkers of Inflammation and Coagulation in Chronic HIV Infection. The Journal of Infectious Diseases. 210(9). 1396–1406. 78 indexed citations

Henry, W. Keith, et al.. (2012). Detection of HPAI H5N1 viruses in ducks sampled from live bird markets in Vietnam. Epidemiology and Infection. 141(3). 601–611. 21 indexed citations

Henry, W. Keith, Payal T. Patel, Timothy J. Bush, et al.. (2011). Progression of Carotid Intima-Media Thickness in a Contemporary Human Immunodeficiency Virus Cohort. Clinical Infectious Diseases. 53(8). 826–835. 62 indexed citations

Baker, Jason V., W. Keith Henry, & James D. Neaton. (2009). The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms. Current Opinion in HIV and AIDS. 4(3). 176–182. 37 indexed citations

Henry, W. Keith, et al.. (2009). Management of HIV: a swing back to the future.. PubMed. 92(10). 45–9. 1 indexed citations

Baker, Jason V., Grace Peng, Joshua Rapkin, et al.. (2008). CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS. 22(7). 841–848. 287 indexed citations

Currier, Judith S., Michelle A. Kendall, W. Keith Henry, et al.. (2007). Progression of carotid artery intima–media thickening in HIV-infected and uninfected adults. AIDS. 21(9). 1137–1145. 107 indexed citations

Aberg, Judith A., Robert Zackin, Susan W. Brobst, et al.. (2005). A Randomized Trial of the Efficacy and Safety of Fenofibrate versus Pravastatin in HIV-Infected Subjects with Lipid Abnormalities: AIDS Clinical Trials Group Study 5087. AIDS Research and Human Retroviruses. 21(9). 757–767. 97 indexed citations

Currier, Judith S., Michelle A. Kendall, Robert Zackin, et al.. (2005). Carotid artery intima–media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure. AIDS. 19(9). 927–933. 143 indexed citations

10.

Dubé, Michael P., James H. Stein, Judith A. Aberg, et al.. (2003). Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clinical Infectious Diseases. 37(5). 613–627. 465 indexed citations

11.

Mayer, Kenneth H., Michael P. Dubé, Dennis L. Sprecher, et al.. (2000). Preliminary Guidelines for the Evaluation and Management of Dyslipidemia in Adults Infected with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group. Clinical Infectious Diseases. 31(5). 1216–1224. 166 indexed citations

12.

Henry, W. Keith, et al.. (1997). HIV RNA quantitation: Marker of HIV infection. Journal of the Association of Nurses in AIDS Care. 8(5). 31–38. 2 indexed citations

13.

Hammer, Scott M., David Katzenstein, Michael D. Hughes, et al.. (1996). A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter. New England Journal of Medicine. 335(15). 1081–1090. 768 indexed citations breakdown →

14.

Balfour, Henry H., Courtney V. Fletcher, Alejo Erice, et al.. (1996). Effect of foscarnet on quantities of cytomegalovirus and human immunodeficiency virus in blood of persons with AIDS. Antimicrobial Agents and Chemotherapy. 40(12). 2721–2726. 24 indexed citations

15.

Fletcher, Courtney V., et al.. (1995). The Effect of Cimetidine and Ranitidine Administration With Zidovudine. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 15(6). 701–708. 16 indexed citations

16.

Henry, W. Keith, et al.. (1995). Strategies for control of zidovudine concentrations in serum. Antimicrobial Agents and Chemotherapy. 39(12). 2792–2797. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact